Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue inhibitors of metalloproteinases (TIMPs)
- Target
- TIMPs
- Molecular classification
- Protease inhibitors
01
Overview
Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs). They play a crucial role in regulating extracellular matrix turnover and cell behavior, influencing processes such as cell proliferation, apoptosis, and tumor progression. TIMPs consist of four family members, each with distinct roles but overlapping functions in inhibiting metalloproteinases. They are involved in various diseases, including cancer, cardiovascular diseases, and neurological conditions.
- Other names
- tissue inhibitors of metalloproteinasesTIMP-1TIMP-2TIMP-3TIMP-4
02
Mechanism of action
TIMPs primarily work by inhibiting MMP activity, thus regulating extracellular matrix turnover and cellular behavior.
03
Biological functions
Inhibition of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs)Modulation of extracellular matrix turnoverSignal transduction (e.g., through interactions with cell surface receptors like CD63)Cell proliferationApoptosis regulation
04
Disease associations
Cancer: TIMPs can have both tumor-suppressive and tumor-promoting roles depending on the context.Cardiovascular disease: Matrix remodeling is crucial in cardiovascular health.Other roles include involvement in neurological and inflammatory processes.
05
Safety considerations
Imbalance in MMP/TIMP levels leading to various pathological conditions rather than direct safety issues with TIMPs themselves.
06
Biomarkers
TIMPsTIMP-1
Beyond the preview
Go deeper on Tissue inhibitors of metalloproteinases (TIMPs).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tissue inhibitors of metalloproteinases (TIMPs).